Literature DB >> 22286948

The active ClpP protease from M. tuberculosis is a complex composed of a heptameric ClpP1 and a ClpP2 ring.

Tatos Akopian1, Olga Kandror, Ravikiran M Raju, Meera Unnikrishnan, Eric J Rubin, Alfred L Goldberg.   

Abstract

Mycobacterium tuberculosis (Mtb) contains two clpP genes, both of which are essential for viability. We expressed and purified Mtb ClpP1 and ClpP2 separately. Although each formed a tetradecameric structure and was processed, they lacked proteolytic activity. We could, however, reconstitute an active, mixed ClpP1P2 complex after identifying N-blocked dipeptides that stimulate dramatically (>1000-fold) ClpP1P2 activity against certain peptides and proteins. These activators function cooperatively to induce the dissociation of ClpP1 and ClpP2 tetradecamers into heptameric rings, which then re-associate to form the active ClpP1P2 2-ring mixed complex. No analogous small molecule-induced enzyme activation mechanism involving dissociation and re-association of multimeric rings has been described. ClpP1P2 possesses chymotrypsin and caspase-like activities, and ClpP1 and ClpP2 differ in cleavage preferences. The regulatory ATPase ClpC1 was purified and shown to increase hydrolysis of proteins by ClpP1P2, but not peptides. ClpC1 did not activate ClpP1 or ClpP2 homotetradecamers and stimulated ClpP1P2 only when both ATP and a dipeptide activator were present. ClpP1P2 activity, its unusual activation mechanism and ClpC1 ATPase represent attractive drug targets to combat tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22286948      PMCID: PMC3321190          DOI: 10.1038/emboj.2012.5

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  64 in total

1.  Human mitochondrial ClpP is a stable heptamer that assembles into a tetradecamer in the presence of ClpX.

Authors:  Sung Gyun Kang; Mariana N Dimitrova; Joaquin Ortega; Ann Ginsburg; Michael R Maurizi
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

2.  Dysregulation of bacterial proteolytic machinery by a new class of antibiotics.

Authors:  Heike Brötz-Oesterhelt; Dieter Beyer; Hein-Peter Kroll; Rainer Endermann; Christoph Ladel; Werner Schroeder; Berthold Hinzen; Siegfried Raddatz; Holger Paulsen; Kerstin Henninger; Julia E Bandow; Hans-Georg Sahl; Harald Labischinski
Journal:  Nat Med       Date:  2005-10-02       Impact factor: 53.440

Review 3.  Self-compartmentalized bacterial proteases and pathogenesis.

Authors:  Susan M Butler; Richard A Festa; Michael J Pearce; K Heran Darwin
Journal:  Mol Microbiol       Date:  2006-05       Impact factor: 3.501

4.  Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate.

Authors:  Alexei F Kisselev; Alice Callard; Alfred L Goldberg
Journal:  J Biol Chem       Date:  2006-02-02       Impact factor: 5.157

Review 5.  The proteasome: paradigm of a self-compartmentalizing protease.

Authors:  W Baumeister; J Walz; F Zühl; E Seemüller
Journal:  Cell       Date:  1998-02-06       Impact factor: 41.582

6.  The structure of ClpP at 2.3 A resolution suggests a model for ATP-dependent proteolysis.

Authors:  J Wang; J A Hartling; J M Flanagan
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

7.  Molecular properties of ClpAP protease of Escherichia coli: ATP-dependent association of ClpA and clpP.

Authors:  M R Maurizi; S K Singh; M W Thompson; M Kessel; A Ginsburg
Journal:  Biochemistry       Date:  1998-05-26       Impact factor: 3.162

Review 8.  New insights into the ATP-dependent Clp protease: Escherichia coli and beyond.

Authors:  J Porankiewicz; J Wang; A K Clarke
Journal:  Mol Microbiol       Date:  1999-05       Impact factor: 3.501

9.  The asymmetry in the mature amino-terminus of ClpP facilitates a local symmetry match in ClpAP and ClpXP complexes.

Authors:  Maria C Bewley; Vito Graziano; Kathleen Griffin; John M Flanagan
Journal:  J Struct Biol       Date:  2005-12-01       Impact factor: 2.867

10.  The role of the ClpA chaperone in proteolysis by ClpAP.

Authors:  J R Hoskins; M Pak; M R Maurizi; S Wickner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

View more
  53 in total

1.  The purification of the Chlamydomonas reinhardtii chloroplast ClpP complex: additional subunits and structural features.

Authors:  Benoît Derrien; Wojciech Majeran; Grégory Effantin; Joseph Ebenezer; Giulia Friso; Klaas J van Wijk; Alasdair C Steven; Michael R Maurizi; Olivier Vallon
Journal:  Plant Mol Biol       Date:  2012-07-08       Impact factor: 4.076

2.  Lassomycin, a ribosomally synthesized cyclic peptide, kills mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2.

Authors:  Ekaterina Gavrish; Clarissa S Sit; Shugeng Cao; Olga Kandror; Amy Spoering; Aaron Peoples; Losee Ling; Ashley Fetterman; Dallas Hughes; Anthony Bissell; Heather Torrey; Tatos Akopian; Andreas Mueller; Slava Epstein; Alfred Goldberg; Jon Clardy; Kim Lewis
Journal:  Chem Biol       Date:  2014-03-27

3.  Initial Characterization of the Two ClpP Paralogs of Chlamydia trachomatis Suggests Unique Functionality for Each.

Authors:  Nicholas A Wood; Krystal Y Chung; Amanda M Blocker; Nathalia Rodrigues de Almeida; Martin Conda-Sheridan; Derek J Fisher; Scot P Ouellette
Journal:  J Bacteriol       Date:  2018-12-20       Impact factor: 3.490

4.  Structural basis of mycobacterial inhibition by cyclomarin A.

Authors:  Dileep Vasudevan; Srinivasa P S Rao; Christian G Noble
Journal:  J Biol Chem       Date:  2013-09-10       Impact factor: 5.157

5.  Acyldepsipeptide antibiotics kill mycobacteria by preventing the physiological functions of the ClpP1P2 protease.

Authors:  Kirsten Famulla; Peter Sass; Imran Malik; Tatos Akopian; Olga Kandror; Marina Alber; Berthold Hinzen; Helga Ruebsamen-Schaeff; Rainer Kalscheuer; Alfred L Goldberg; Heike Brötz-Oesterhelt
Journal:  Mol Microbiol       Date:  2016-04-01       Impact factor: 3.501

6.  Crystal structure of Mycobacterium tuberculosis ClpP1P2 suggests a model for peptidase activation by AAA+ partner binding and substrate delivery.

Authors:  Karl R Schmitz; Daniel W Carney; Jason K Sello; Robert T Sauer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

7.  Structure and activation of a heteromeric protease complex.

Authors:  Jing Liu; Peter Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

Review 8.  The Bewildering Antitubercular Action of Pyrazinamide.

Authors:  Elise A Lamont; Nicholas A Dillon; Anthony D Baughn
Journal:  Microbiol Mol Biol Rev       Date:  2020-03-04       Impact factor: 11.056

9.  Mycobacterium tuberculosis ESAT-6 exhibits a unique membrane-interacting activity that is not found in its ortholog from non-pathogenic Mycobacterium smegmatis.

Authors:  Joaquin De Leon; Guozhong Jiang; Yue Ma; Eric Rubin; Sarah Fortune; Jianjun Sun
Journal:  J Biol Chem       Date:  2012-11-13       Impact factor: 5.157

10.  Antibacterial activity of and resistance to small molecule inhibitors of the ClpP peptidase.

Authors:  Corey L Compton; Karl R Schmitz; Robert T Sauer; Jason K Sello
Journal:  ACS Chem Biol       Date:  2013-10-04       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.